BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27910191)

  • 21. Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.
    Espinel-Ingroff A; Abreu DPB; Almeida-Paes R; Brilhante RSN; Chakrabarti A; Chowdhary A; Hagen F; Córdoba S; Gonzalez GM; Govender NP; Guarro J; Johnson EM; Kidd SE; Pereira SA; Rodrigues AM; Rozental S; Szeszs MW; Ballesté Alaniz R; Bonifaz A; Bonfietti LX; Borba-Santos LP; Capilla J; Colombo AL; Dolande M; Isla MG; Melhem MSC; Mesa-Arango AC; Oliveira MME; Panizo MM; Pires de Camargo Z; Zancope-Oliveira RM; Meis JF; Turnidge J
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
    Rosa PD; Heidrich D; Corrêa C; Scroferneker ML; Vettorato G; Fuentefria AM; Goldani LZ
    Mycoses; 2017 Sep; 60(9):616-622. PubMed ID: 28657120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifungal Susceptibility, Morphological and Molecular Characterization of Lasiodiplodia theobromae Isolated from a Patient with Keratitis.
    da Rosa PD; Locatelli C; Scheid K; Marinho D; Kliemann L; Fuentefria A; Goldani LZ
    Mycopathologia; 2018 Jun; 183(3):565-571. PubMed ID: 29383575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods.
    Iqbal NJ; Boey A; Park BJ; Brandt ME
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):348-50. PubMed ID: 18707841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug combinations against Mucor irregularis in vitro.
    Zhang S; Li R; Yu J
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3395-7. PubMed ID: 23587956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications.
    McGinnis MR; Pasarell L
    J Clin Microbiol; 1998 Aug; 36(8):2353-5. PubMed ID: 9666022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin and terbinafine against Scytalidium dimidiatum and Scytalidium hyalinum clinical isolates.
    Lacroix C; de Chauvin MF
    J Antimicrob Chemother; 2008 Apr; 61(4):835-7. PubMed ID: 18218642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
    Li L; Wang Z; Li R; Luo S; Sun X
    Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
    Cuenca-Estrella M; Gomez-Lopez A; Garcia-Effron G; Alcazar-Fuoli L; Mellado E; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1232-5. PubMed ID: 15728937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.
    Drogari-Apiranthitou M; Mantopoulou FD; Skiada A; Kanioura L; Grammatikou M; Vrioni G; Mitroussia-Ziouva A; Tsakris A; Petrikkos G
    J Antimicrob Chemother; 2012 Aug; 67(8):1937-40. PubMed ID: 22535624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China.
    Yu J; Li R; Zhang M; Liu L; Wan Z
    Med Mycol; 2008 Nov; 46(7):745-7. PubMed ID: 18608889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Species diversity, antifungal susceptibility and phenotypic and genotypic characterisation of Exophiala spp. infecting patients in different medical centres in Brazil.
    Silva WC; Gonçalves SS; Santos DW; Padovan AC; Bizerra FC; Melo AS
    Mycoses; 2017 May; 60(5):328-337. PubMed ID: 28139861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs.
    Shobana CS; Mythili A; Homa M; Galgóczy L; Priya R; Babu Singh YR; Panneerselvam K; Vágvölgyi C; Kredics L; Narendran V; Manikandan P
    J Mycol Med; 2015 Mar; 25(1):44-9. PubMed ID: 25541256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Photodynamic Therapy on the Growth and Antifungal Susceptibility of Scedosporium and Lomentospora spp.
    Lu Q; Sun Y; Tian D; Xiang S; Gao L
    Mycopathologia; 2017 Dec; 182(11-12):1037-1043. PubMed ID: 28836110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
    Espinel-Ingroff A
    Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
    Espinel-Ingroff A; Arthington-Skaggs B; Iqbal N; Ellis D; Pfaller MA; Messer S; Rinaldi M; Fothergill A; Gibbs DL; Wang A
    J Clin Microbiol; 2007 Jun; 45(6):1811-20. PubMed ID: 17428932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro antifungal susceptibility of clinical isolates of Arthrographis kalrae, a poorly known opportunistic fungus.
    Sandoval-Denis M; Giraldo A; Sutton DA; Fothergill AW; Guarro J
    Mycoses; 2014 Apr; 57(4):247-8. PubMed ID: 24147779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi.
    McGinnis MR; Pasarell L
    Med Mycol; 1998 Aug; 36(4):243-6. PubMed ID: 9776842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.